What are you looking for?

DePuy Hip Replacement Articles

Is the DePuy Hip Replacement a Dangerous Device?

May 23, 2012. By Heidi Turner.

Atlanta, GA: When patients first received their DePuy ASR hip replacement device, they likely thought their pain was going to lessen and their mobility problems would be over. But some patients who received that particular metal-on-metal DePuy hip replacement have found that the surgery was only the start of their ordeal. Following the announcement of the DePuy ASR recall, and subsequent DePuy lawsuits, some critics say that the DePuy ASR is a dangerous device.

Read [ Is the DePuy Hip Replacement a Dangerous Device? ]

Health Canada Issues Warning on Hip and Knee Replacement Failure

May 15, 2012. By Heidi Turner.

Toronto, Canada: Health Canada has joined other agencies and experts in warning about the risks associated with hip and knee replacement implant failure. Specifically, the health agency warned about the risks associated with metal-on-metal hip implants. Complaints about hip implant failures have resulted in hip replacement lawsuits, alleging the metal-on-metal hip replacement devices were defective and have a higher rate of failure than traditional hip replacement devices.

Read [ Health Canada Issues Warning on Hip and Knee Replacement Failure ]

Consumer Reports Takes On DePuy Hip Replacement

May 11, 2012. By Gordon Gibb.

Washington, DC: One has to wonder if we might be better off if the Consumers Union regulated the country's medical device industry, rather than the US Food and Drug Administration (FDA). Consumers Union publishes the venerable Consumer Reports magazine, a bastion of independent thought and testing upon which consumers have come to rely for unbiased ratings of products. But DePuy Hip replacement?

Read [ Consumer Reports Takes On DePuy Hip Replacement ]

FDA Wants Expert Advice on DePuy Hip Implants

April 24, 2012. By Charles Benson.

Washington, DC: The Food and Drug Administration (FDA) will be asking an advisory panel of experts to take a closer look at metal-on-metal implants, as calls for action were made following a large hip replacement recall, Reuters reported.

Read [ FDA Wants Expert Advice on DePuy Hip Implants ]

DePuy Hip Replacement Phased Out After FDA Letter

April 12, 2012. By Heidi Turner.

New York, NY: Following reports that DePuy allegedly knew about problems with its DePuy hip prior to the DePuy hip replacement recall come reports that Johnson & Johnson—parent company to DePuy—received a request for information from the US Food and Drug Administration (FDA) just prior to the company's decision to phase out its hip replacement device.

Read [ DePuy Hip Replacement Phased Out After FDA Letter ]

FDA Panel to Review Metal-on-Metal Hip Replacements

March 29, 2012. By Lucy Campbell.

Washington, DC: The U.S. Food and Drug Administration (FDA) has just announced that it is seeking expert scientific and clinical advice on the risks and benefits of metal-on-metal (MoM) hip systems. The agency is also looking to develop potential patient and practitioner recommendations on the use of MoM hip systems and the management of patients implanted with such devices.

Read [ FDA Panel to Review Metal-on-Metal Hip Replacements ]

DePuy ASR Hip Failed Woman within Two Years

March 25, 2012. By Gordon Gibb.

Rosemount, MN: Yet another example of the potential liability inherent with metal-on-metal replacement hip devices was borne out in a recent report carried in the Star Tribune (Minneapolis, 3/12/12) and the plight of Terri Wagner-Morley. The Minnesota woman received a DePuy hip replacement system, only to have it fail.

Read [ DePuy ASR Hip Failed Woman within Two Years ]

BMJ: Metal-on-Metal Hip Replacements a "Large Uncontrolled Experiment"

March 9, 2012. By Heidi Turner.

Akron, OH: When consumers think of leaking implants, they tend to think of breast implants, not DePuy hip replacements. But according to reports, some experts are concerned that the DePuy ASR, which was subject to a massive DePuy hip implant recall in 2010, could cause more damage than breast implants.

Read [ BMJ: Metal-on-Metal Hip Replacements a "Large Uncontrolled Experiment" ]

Executive Discussed Failures of DePuy Hip Replacement Prior to FDA Warning

February 27, 2012. By Charles Benson.

Washington, DC: A year before recalling an artificial hip, an executive at Johnson & Johnson reported in an internal e-mail that the US Food and Drug Administration had refused to approve a DePuy Hip Replacement after reviewing company studies that showed it had failed prematurely in "significant" numbers, leading to repeat surgeries for patients, The New York Times reported.

Read [ Executive Discussed Failures of DePuy Hip Replacement Prior to FDA Warning ]

How Much Did DePuy Know About Hip Implant Failure?

February 22, 2012. By Heidi Turner.

Washington, DC: A recent report from The New York Times (2/21/12) indicates that DePuy Orthopaedics knew well before its hip implant recall was announced that its all-metal devices were failing prematurely. Certain DePuy devices were recalled in 2010 following reports of high hip replacement failure. As The New York Times report shows, however, not only was DePuy likely aware of problems with hip implant failure, the FDA had rejected one of the company's recalled devices because of the high failure rate.

Read [ How Much Did DePuy Know About Hip Implant Failure? ]